Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 6.1
edited by Sarantis Dimitriadis
on 2023/05/30 09:33
Change comment: There is no comment for this version
To version 5.4
edited by Sarantis Dimitriadis
on 2022/06/02 10:00
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,8 +7,6 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 -:
11 -
12 12  * (((
13 13  (% lang="en-US" %)**Non-professional end users:**
14 14  
... ... @@ -17,8 +17,6 @@
17 17  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
18 18  )))
19 19  
20 -:
21 -
22 22  * (((
23 23  (% lang="en-US" %)**Professional end users**
24 24  
... ... @@ -29,13 +29,9 @@
29 29  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
30 30  )))
31 31  
32 -:
33 -
34 34  (% class="western" lang="en-GB" %)
35 35  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
36 36  
37 -:
38 -
39 39  * (((
40 40  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
41 41  
... ... @@ -50,8 +50,6 @@
50 50  * (% lang="en-US" %)Pharmaceutical companies
51 51  )))
52 52  
53 -:
54 -
55 55  * (((
56 56  (% lang="en-GB" %)
57 57  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -67,8 +67,6 @@
67 67  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
68 68  )))
69 69  
70 -:
71 -
72 72  * (((
73 73  (% lang="en-GB" %)
74 74  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -82,8 +82,6 @@
82 82  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
83 83  )))
84 84  
85 -:
86 -
87 87  * (((
88 88  (% lang="en-GB" %)
89 89  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -91,8 +91,6 @@
91 91  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
92 92  )))
93 93  
94 -:
95 -
96 96  * (((
97 97  (% lang="en-GB" %)
98 98  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -101,89 +101,276 @@
101 101  * (% lang="en-US" %)International, national, regional and local networks
102 102  )))
103 103  
104 -:
105 -
106 106  (% class="western" lang="en-GB" %)
107 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
89 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
108 108  
109 -(% style="height:1004px; margin-left:auto; margin-right:auto; width:1694px" %)
110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
112 -(% lang="en-US" %)Specific age range
113 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
91 +
92 +(% cellspacing="0" class="table-striped" dir="ltr" style="margin-left:auto; margin-right:auto" %)
93 +|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)(((
94 +(% class="western" lang="en-GB" style="text-align:center" %)
95 +(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group**
96 +)))
97 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
98 +(% class="western" lang="en-GB" %)
99 +(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range
100 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
101 +(% class="western" %)
114 114  
115 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
103 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
116 116  (% class="western" %)
117 117  
118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
106 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
119 119  (% class="western" %)
120 120  
121 121  )))
122 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
110 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
111 +(% class="western" lang="en-GB" %)
112 +(% lang="en-US" style="font-family:Calibri,serif" %)Elderly
113 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
114 +(% class="western" lang="en-GB" %)
115 +(% lang="en-US" style="font-family:Calibri,serif" %)Adults
116 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
117 +(% class="western" lang="en-GB" %)
118 +(% lang="en-US" style="font-family:Calibri,serif" %)Youth
119 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
120 +(% class="western" lang="en-GB" %)
121 +(% lang="en-US" style="font-family:Calibri,serif" %)Children
122 +)))
123 +|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
124 124  (% class="western" %)
125 125  
126 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
127 +(% class="western" %)
128 +
129 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
130 +(% class="western" %)
131 +
132 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
133 +(% class="western" %)
134 +
126 126  )))
127 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
128 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
136 +|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
137 +(% class="western" lang="en-GB" style="text-align:center" %)
138 +(% lang="en-US" style="font-family:Calibri,serif" %)**Health status**
139 +)))
140 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
129 129  (% class="western" lang="en-GB" %)
130 -(% lang="en-US" %)Healthy
131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
142 +(% lang="en-US" style="font-family:Calibri,serif" %)Healthy
143 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
132 132  (% class="western" lang="en-GB" %)
133 -
134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
145 +(% lang="en-US" style="font-family:Calibri,serif" %)Patient
146 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
135 135  (% class="western" lang="en-GB" %)
136 -
137 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
148 +(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant
149 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
138 138  (% class="western" lang="en-GB" %)
139 -
151 +(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor
140 140  )))
141 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
153 +|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
142 142  (% class="western" %)
143 143  
144 -)))
145 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Schizophrenia|Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)Parkinson Disease
147 -|Post-Stroke Patients with Moving or Linguistic Disability|Mild Cognitive Impairment|Sleep Disorders: e.g., Apnea, Hypopnea|With Disability
148 -|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)
149 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
156 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
150 150  (% class="western" %)
151 151  
159 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
160 +(% class="western" %)
161 +
162 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
163 +(% class="western" %)
164 +
152 152  )))
153 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
154 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Parkinson Disease|Mild Cognitive Impairment|With Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
166 +|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
167 +(% class="western" lang="en-GB" style="text-align:center" %)
168 +(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability**
169 +)))
170 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
171 +(% class="western" lang="en-GB" %)
172 +(% lang="en-US" style="font-family:Calibri,serif" %)ADHD
173 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
174 +(% class="western" lang="en-GB" %)
175 +(% lang="en-US" style="font-family:Calibri,serif" %)Dementia
176 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
177 +(% class="western" lang="en-GB" %)
178 +(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease
179 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
180 +(% class="western" lang="en-GB" %)
181 +(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation
182 +)))
183 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
184 +(% class="western" lang="en-GB" %)
185 +(% lang="en-US" style="font-family:Calibri,serif" %)Autism
186 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
187 +(% class="western" lang="en-GB" %)
188 +(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome
189 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
190 +(% class="western" lang="en-GB" %)
191 +(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability
192 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
193 +(% class="western" lang="en-GB" %)
194 +(% lang="en-US" style="font-family:Calibri,serif" %)Mental health
195 +)))
196 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
197 +(% class="western" lang="en-GB" %)
198 +(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease
199 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
200 +(% class="western" lang="en-GB" %)
201 +(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF)
202 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
203 +(% class="western" lang="en-GB" %)
204 +(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea
205 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
206 +(% class="western" lang="en-GB" %)
207 +(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment
208 +)))
209 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
210 +(% class="western" lang="en-GB" %)
211 +(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD)
212 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
213 +(% class="western" lang="en-GB" %)
214 +(% lang="en-US" style="font-family:Calibri,serif" %)Language disability
215 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
216 +(% class="western" lang="en-GB" %)
217 +(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol)
218 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
219 +(% class="western" lang="en-GB" %)
220 +(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis
221 +)))
222 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
223 +(% class="western" lang="en-GB" %)
224 +(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major)
225 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
226 +(% class="western" lang="en-GB" %)
227 +(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation
228 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
229 +(% class="western" lang="en-GB" %)
230 +(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient
231 +
232 +(% class="western" lang="en-GB" %)
233 +(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury)
234 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
235 +(% class="western" lang="en-GB" %)
236 +(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases
237 +)))
238 +|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
155 155  (% class="western" %)
156 156  
241 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
242 +(% class="western" %)
243 +
244 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
245 +(% class="western" %)
246 +
247 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
248 +(% class="western" %)
249 +
157 157  )))
158 -|Healthy with Possible Chronic Conditions|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
251 +|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
252 +(% class="western" lang="en-GB" style="text-align:center" %)
253 +(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service**
254 +)))
255 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
159 159  (% class="western" lang="en-GB" %)
257 +(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare
258 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
259 +(% class="western" lang="en-GB" %)
260 +(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home
261 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
262 +(% class="western" lang="en-GB" %)
263 +(% lang="en-US" style="font-family:Calibri,serif" %)Employment service
264 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
265 +(% class="western" %)
160 160  
161 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
267 +)))
268 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
162 162  (% class="western" lang="en-GB" %)
270 +(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education
271 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
272 +(% class="western" lang="en-GB" %)
273 +(% lang="en-US" style="font-family:Calibri,serif" %)Home care
274 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
275 +(% class="western" lang="en-GB" %)
163 163  
164 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
277 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
165 165  (% class="western" lang="en-GB" %)
166 166  
167 167  )))
168 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
281 +|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
169 169  (% class="western" %)
170 170  
284 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
285 +(% class="western" %)
286 +
287 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)(((
288 +(% class="western" %)
289 +
290 +)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)(((
291 +(% class="western" %)
292 +
171 171  )))
172 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
173 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Healthy|Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
294 +|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
295 +(% class="western" lang="en-GB" style="text-align:center" %)
296 +(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups**
297 +)))
298 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
174 174  (% class="western" lang="en-GB" %)
175 -Down Syndrome
300 +(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children
301 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
302 +(% class="western" lang="en-GB" %)
303 +(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children
304 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
305 +(% class="western" lang="en-GB" %)
306 +(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence
307 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
308 +(% class="western" lang="en-GB" %)
309 +(% lang="en-US" style="font-family:Calibri,serif" %)Substance users
310 +
311 +(% class="western" lang="en-GB" %)
312 +(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol)
176 176  )))
177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
314 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
178 178  (% class="western" lang="en-GB" %)
316 +(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people
317 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
318 +(% class="western" lang="en-GB" %)
319 +(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings
320 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
321 +(% class="western" lang="en-GB" %)
322 +(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants
323 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
324 +(% class="western" lang="en-GB" %)
325 +(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people
326 +)))
327 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
328 +(% class="western" lang="en-GB" %)
329 +(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people
330 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
331 +(% class="western" lang="en-GB" %)
332 +(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses
333 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
334 +(% class="western" lang="en-GB" %)
335 +(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people
336 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
337 +(% class="western" lang="en-GB" %)
338 +(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background
339 +)))
340 +|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
341 +(% class="western" lang="en-GB" %)
342 +(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women
343 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
344 +(% class="western" lang="en-GB" %)
345 +(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders
346 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
347 +(% class="western" lang="en-GB" %)
179 179  
349 +)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
350 +(% class="western" lang="en-GB" %)
351 +
180 180  )))
181 181  
182 -:
183 -
184 184  (% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
355 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
186 186  
357 +
187 187  |**Researcher expertise**|**Brief use case description**
188 188  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
189 189  |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project